These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 12138687

  • 21. [Idiopathic thrombocytopenic purpura associated with mantle cell lymphoma showing an increase in the platelet count receiving anti-CD20 antibody rituximab].
    Kawachi Y, Ide M, Uchida T, Setsu K.
    Rinsho Ketsueki; 2003 Jan; 44(1):31-3. PubMed ID: 12649836
    [Abstract] [Full Text] [Related]

  • 22. [Rituximab treatment for adults with steroid-resistant idiopathic thrombocytopenic purpura].
    Wang W, Yu QH, Zhang HY, Chu XX, Chen F, Zhang CQ, Zhou YH, Hou M.
    Zhonghua Nei Ke Za Zhi; 2008 Mar; 47(3):225-7. PubMed ID: 18785508
    [Abstract] [Full Text] [Related]

  • 23. Rituximab therapy for chronic and refractory immune thrombocytopenic purpura: a long-term follow-up analysis.
    Garcia-Chavez J, Majluf-Cruz A, Montiel-Cervantes L, Esparza MG, Vela-Ojeda J, Mexican Hematology Study Group.
    Ann Hematol; 2007 Dec; 86(12):871-7. PubMed ID: 17874322
    [Abstract] [Full Text] [Related]

  • 24. [Clinical study of standard dose of rituximab for the treatment of refractory primary immune thrombocytopenia].
    Zhu YC, Wang W, Zhou YH, Wang XM, Wang X, Wang YL, Sun GZ, Hou M.
    Zhonghua Xue Ye Xue Za Zhi; 2011 Mar; 32(3):163-7. PubMed ID: 21535953
    [Abstract] [Full Text] [Related]

  • 25. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.
    Stasi R, Stipa E, Del Poeta G, Amadori S, Newland AC, Provan D.
    Rheumatology (Oxford); 2006 Nov; 45(11):1432-6. PubMed ID: 16632482
    [Abstract] [Full Text] [Related]

  • 26. Effect of a single dose of rituximab in chronic immune thrombocytopenic purpura in childhood.
    Taube T, Schmid H, Reinhard H, von Stackelberg A, Overberg US.
    Haematologica; 2005 Feb; 90(2):281-3. PubMed ID: 15710595
    [Abstract] [Full Text] [Related]

  • 27. [Clinical efficacy of lower dose rituximab for chronic refractory immune thrombocytopenic purpura].
    Li Y, Wang XM, Mao M, Zhang XY, Fu L, Ai HM, Zhang LX.
    Zhonghua Xue Ye Xue Za Zhi; 2012 Mar; 33(3):204-6. PubMed ID: 22781608
    [Abstract] [Full Text] [Related]

  • 28. Single-agent rituximab as first-line and maintenance treatment for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma: a phase II trial of the Minnie Pearl Cancer Research Network.
    Hainsworth JD, Litchy S, Barton JH, Houston GA, Hermann RC, Bradof JE, Greco FA, Minnie Pearl Cancer Research Network.
    J Clin Oncol; 2003 May 01; 21(9):1746-51. PubMed ID: 12721250
    [Abstract] [Full Text] [Related]

  • 29. Treatment of a patient with chronic immune thrombocytopenic purpura with rituximab and monitoring by flow cytometric analysis.
    Thude H, Gruhn B, Werner U, Schorner U, Häfer R, Zintl F, Barz D.
    Acta Haematol; 2004 May 01; 111(4):221-4. PubMed ID: 15153715
    [Abstract] [Full Text] [Related]

  • 30. Chronic immune thrombocytopenic purpura in children: assessment of rituximab treatment.
    Wang J, Wiley JM, Luddy R, Greenberg J, Feuerstein MA, Bussel JB.
    J Pediatr; 2005 Feb 01; 146(2):217-21. PubMed ID: 15689912
    [Abstract] [Full Text] [Related]

  • 31. [Effective treatment with rituximab in a patient with refractory idiopathic thrombocytopenic purpura].
    Tanai C, Iki S, Nakahara F, Iijima K, Usuki K, Kuwana M, Urabe A.
    Rinsho Ketsueki; 2004 Nov 01; 45(11):1181-6. PubMed ID: 15609684
    [Abstract] [Full Text] [Related]

  • 32. Rituximab: an anti-CD20 antibody for the treatment of chronic refractory immune thrombocytopenic purpura.
    Aggarwal A, Catlett JP.
    South Med J; 2002 Oct 01; 95(10):1209-12. PubMed ID: 12425512
    [Abstract] [Full Text] [Related]

  • 33. Clinical efficacy and safety of Flebogammadif, a new high-purity human intravenous immunoglobulin, in adult patients with chronic idiopathic thrombocytopenic purpura.
    Julia A, Kovaleva L, Loria S, Alberca I, Hernandez F, Sandoval V, Sierra J, Vidaller A, Ayguasanosa J, Carretero M.
    Transfus Med; 2009 Oct 01; 19(5):260-8. PubMed ID: 19747289
    [Abstract] [Full Text] [Related]

  • 34. Rituximab for refractory Evans syndrome and other immune-mediated hematologic diseases.
    Mantadakis E, Danilatou V, Stiakaki E, Kalmanti M.
    Am J Hematol; 2004 Nov 01; 77(3):303-10. PubMed ID: 15495242
    [Abstract] [Full Text] [Related]

  • 35. A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopenia.
    Saleh MN, Gutheil J, Moore M, Bunch PW, Butler J, Kunkel L, Grillo-López AJ, LoBuglio AF.
    Semin Oncol; 2000 Dec 01; 27(6 Suppl 12):99-103. PubMed ID: 11226008
    [Abstract] [Full Text] [Related]

  • 36. Efficacy of amifostine in treating patients with idiopathic thrombocytopenia purpura.
    Fan H, Zhu HL, Li SX, Lu XC, Zhai B, Guo B, Yao SQ, Liu Y.
    Cell Biochem Biophys; 2011 Jan 01; 59(1):7-12. PubMed ID: 21104159
    [Abstract] [Full Text] [Related]

  • 37. The role of autoantibody-producing plasma cells in immune thrombocytopenic purpura refractory to rituximab.
    Kuwana M, Iki S, Urabe A.
    Am J Hematol; 2007 Sep 01; 82(9):846-8. PubMed ID: 17506067
    [Abstract] [Full Text] [Related]

  • 38. Very long-term remission induced by short-term rituximab monotherapy in a patient with heavily pretreated, chronic immune thrombocytopenic purpura.
    Clausen MR, Segel E, Brandsborg M, d'Amore F.
    Eur J Haematol; 2011 Mar 01; 86(3):256-9. PubMed ID: 21166717
    [Abstract] [Full Text] [Related]

  • 39. Critical issues of current and future developments in the treatment of immune thrombocytopenic purpura.
    Koene HR.
    Pediatr Blood Cancer; 2006 Oct 15; 47(5 Suppl):703-5. PubMed ID: 16933273
    [Abstract] [Full Text] [Related]

  • 40. Clinical remission following monoclonal anti-CD20 therapy in two children with chronic refractory idiopathic thrombocytopenic purpura.
    Moschovi M, Trimis G, Pergantou H, Platokouki H, Vrachnou E, Tzortzatou-Stathopoulou F.
    J Paediatr Child Health; 2005 Jul 15; 41(7):384-6. PubMed ID: 16014149
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.